Final Report: SmartFlow Glaucoma Stent

In the United States, Glaucoma affects over three million people and has become the second leading cause for blindness. Currently, a barrage of different techniques are used to treat the underlying cause of most Glaucoma cases: high intraocular pressure (IOP). High IOP is the primary cause of open-angle glaucoma and is treated using a variety of drugs, laser surgeries, and traditional surgeries. This report presents the design of an implantable device which will allow for IOP to be measured and controlled using a wireless microelectromechanical systems (MEMS) based device.